Is the ONTARGET renal substudy actually off target?

Daniela Macconi, Susanna Tomasoni, Paola Romagnani, Piera Trionfini, Fabio Sangalli, Benedetta Mazzinghi, Paola Rizzo, Elena Lazzeri, Mauro Abbate, Giuseppe Remuzzi, Ariela Benigni

Article2020

On-target versus off-target effects of drugs inhibiting the replication of SARS-CoV-2

Allan Sauvat, Fabiola Ciccosanti, Francesca Colavita, Martina Di Rienzo, Concetta Castilletti, Maria Rosaria Capobianchi, Oliver Kepp, Laurence Zitvogel, Gian María Fimia, Mauro Piacentini, Guido Guido Kroemer

Article2008

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial

Johannes F.E. Mann, Roland E. Schmieder, Matthew McQueen, Leanne Dyal, Helmut Schumacher, Janice Pogue, Xingyu Wang, Aldo Maggioni, Andrzej Budaj, S Chaithiraphan, Kenneth Dickstein, Matyàs Keltai, Kaj Metsärinne, Ali Oto, Alexander Parkhomenko, Leopoldo Soares Piegas, Tage Lysbo Svendsen, Koon Teo, Salim Yusuf